Pharmafile Logo
Pharmafocus logo
Advanced Search
Takeda image

Takeda announces new cancer collaboration

May 11, 2015
Research and Development, Sales and Marketing Cancer, Europe, Takeda, mental health, ncc

Takeda will be teaming up with Japan’s National Cancer Center (NCC) to develop new cancer drugs. The two organisations have …

News
GSK image

GSK launches new HIV research centre

May 11, 2015
Research and Development, Sales and Marketing AIDS, GSK, HIV, UNC-Chapel Hill, ViiV, qura

GlaxoSmithKline is boosting its philanthropic efforts in R&D into HIV/AIDS by teaming up with academic researchers to launch a new …

News
sandoz image

Novartis invests further into Poland

May 11, 2015
Manufacturing and Production, Sales and Marketing Novartis, Poland, Sandoz, manufacturing, packaging

Sandoz the generics division of Novartis has opened a large packaging centre in Stryków in Poland. Valued at 171 million …

News
harvey_berger

Ariad founder retires

May 11, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ariad, harvey Berger

Dr Harvey Berger the founder of US pharma firm Ariad Pharmaceuticals has announced his decision to retire as chairman and …

Appointment
ViiV founder Dr Manuel Goncalves

Reputation gains from focussing on the patient

May 11, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, HIV, Manuel Goncalves, Pfizer, ViiV

Since being spun-off from GSK and Pfizer, specialist HIV firm ViiV Healthcare has earned the best corporate reputation amongst patients …

Feature
Merck image

Merck to test Keytruda combinations

May 8, 2015
Sales and Marketing BMS, Daiichi Sankyo, Merck, Plexxikon, keytruda, pembrolizumab

Merck will be teaming up with Daiichi Sankyo’s subsidiary Plexxikon to investigate immunotherapy combinations in cancer. A collaborative clinical trial …

News

US Court blocks Novartis biosimilar Neupogen

May 8, 2015
Sales and Marketing Neupogen, Novartis, Zarxio, biosimilar, filagrastim, filgrastim-sndz

Novartis have been temporarily prevented from marketing its biosimilar version of Amgen’s drug Neupogen in the US. Earlier this year …

News
Vaccine image

New malaria vaccine found effective in adults

May 8, 2015
Research and Development, Sales and Marketing Oxford, Plasmodium falciparum, Vaccine, malaria

A new malaria vaccine has shown promise in early stage trials, reducing the risk of contracting the disease by two …

News
GSk image

Boardroom shuffles at GSK and Roche

May 8, 2015
Medical Communications, Sales and Marketing GSK, Novartis, Roche, ViiV, changes, leadership

GlaxoSmithKline and Roche have announced the latest changes to its leadership teams as the companies regroup for the year ahead. …

News
app image

New app can aid tropical disease treatment

May 8, 2015
Medical Communications, Sales and Marketing Merck, app, smartphone, tropical diseases

A new smartphone app is able to automatically detect parasites in the blood and may mark a fundamental shift in …

News
tom_richards

Havas Lynx Group hires three

May 8, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HAVAS LYNX, bainton, linscott, richards

Havas Lynx Group has just bolstered its ranks with the arrival of three new senior appointments. Jon Linscott joins Tim …

Appointment
gilead image

Gilead buys EpiTherapeutics for $65 million

May 7, 2015
Sales and Marketing EpiTherapeutics, Gilead

Gilead is clearly eyeing a future market involving epigenetics as the US firm buys Danish company EpiTherapeutics for $65 million. …

News
J&J image

J&J hands over compassionate use reviews to academics

May 7, 2015
Sales and Marketing J&J, JJ, academics, compac, eap, johnson

Johnson & Johnson has struck a ‘first-of-its-kind partnership’ with academic researchers to review requests for compassionate use of its investigational …

News

Alexion makes $8.4 billion Synageva purchase

May 7, 2015
Research and Development, Sales and Marketing Alexion, Shire, nps, rare disease, synageva

Rare disease specialist firm Alexion is splashing out $8.4 billion to buy fellow US orphan drug developer Synageva biopharmaceuticals. The …

News
Pfizer image

Pfizer names new R&D leaders

May 7, 2015
Research and Development, Sales and Marketing John Lin, Michael Ehlers, Pfizer, rinat

Pfizer has confirmed two key appointments to lead its worldwide research and development organisation with immediate effect. The firm will …

News
Chiesi image

Chiesi rapped for ABPI code breach

May 7, 2015
Medical Communications, Sales and Marketing ABPI, Chiesi, PMCPA

Chiesi made its sales reps go through a ‘tick-box’ compliance training exercise to get the pharma industry regulator ‘off its …

News
michael_zaiac

Celgene appoints European haematology and oncology head

May 7, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, Michael Zaiac

Swiss-based Celgene International Sàrl has appointed Michael Zaiac to the position of vice president of medical affairs for its European haematology …

Appointment
GSK image

Generics continue to erode GSK sales

May 6, 2015
Sales and Marketing GSK, HIV, Novartis, Q1, ViiV, Witty, hampton, respiratory

GlaxoSmithKline’s pharma sales continued to slide in the first quarter of 2015, but ViiV healthcare and the portfolios acquired from …

News
screen_shot_2015-05-06_at_15

ABPI appoints head of medical affairs from GSK

May 6, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Jacintha Sivarajah, acha

The ABPI has appointed Dr Jacintha Sivarajah as the body’s new head of medical affairs. Reporting directly to its executive …

Appointment
screen_shot_2015-05-06_at_11

Lundbeck gains new chief executive from Novo Nordisk

May 6, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kåre Schultz, Lundbeck, Novo Nordisk, Rebien Sorensen

Danish pharma giant Lundbeck has appointed Kåre Schultz as its new president and chief executive. Schultz (pictured) will take up …

Appointment
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026